Bionime Corporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionime with three other
companies in this sector in Taiwan:
Apex Biotechnology Corporation
sales of 1.76 billion Taiwanese Dollars [US$58.15 million]
OK Biotech Co Ltd
(1.04 billion Taiwanese Dollars [US$34.31 million]
of which 100%
was Ok Biotech Co Ltd), and
Cowealth Medical Holding Co Ltd
(2.97 billion Taiwanese Dollars [US$97.80 million]
of which 93%
was Depar. B(Sale Reagent&Other)).
During the year ended December of 2016, sales at
Bionime were 1.74 billion Taiwanese Dollars (US$57.40 million).
increase of 8.1%
versus 2015, when the company's sales were 1.61 billion Taiwanese Dollars.